|
Modeling bladder cancer pathogenesis and tumor evolution
|
1P01CA221757-01A1
|
$1,765,498
|
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Novel platform linking cancer-specific glycosylation with cell signaling outcomes
|
1R21CA229044-01
|
$225,250
|
|
ABBOTT, KAREN
|
UNIV OF ARKANSAS FOR MED SCIS
|
|
University of North Carolina Womens Interagency HIV Study UNC WIHS
|
3U01AI103390-05S1
|
$60,652
|
|
ADIMORA, ADAORA
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Plumbagin in Combination with Vemurafenib for BRAF-mutant Melanoma
|
5R03CA212798-02
|
$74,250
|
|
AFAQ, FARRUKH
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Extending Chimeric Antigen (CAR) T cell therapy to thoracic cancers
|
1P01CA217805-01A1
|
$2,105,511
|
|
ALBELDA, STEVEN
|
UNIVERSITY OF PENNSYLVANIA
|
|
Cell-cell communications create robust collective immunological responses
|
ZIA BC 011728
|
$298,588
|
$74,647
|
Altan-Bonnet, Gregoire
|
CCR (NCI)
|
|
The Molecular Profile of Prostate Tumors in African-American Men
|
ZIA BC 010624
|
$194,781
|
$58,434
|
Ambs, Stefan
|
CCR (NCI)
|
|
Steroid hormone regulation of immune responses
|
1R01CA229400-01
|
$384,018
|
|
ANDERSON, ANA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cancer Metabolism Training Program
|
1T32CA221709-01A1
|
$201,444
|
|
ANN, DAVID
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Clinical trials in women's cancers
|
ZIA BC 011584
|
$206,100
|
$20,610
|
Annunziata, Christina
|
CCR (NCI)
|
|
Immune cell control of ovarian cancer
|
ZIA BC 011775
|
$309,150
|
$154,575
|
Annunziata, Christina
|
CCR (NCI)
|
|
COMPRENDO: Adaptation and Implementation of a Peer-Navigation Intervention to Improve Research Literacy and Diversity in Pediatric Leukemia Clinical Trials
|
1K08CA230306-01
|
$254,821
|
|
ARISTIZABAL, PAULA
|
UNIVERSITY OF CALIFORNIA, SAN DIEGO
|
|
T Cell Alternative p38 Activation Pathway
|
ZIA BC 010774
|
$559,148
|
$139,787
|
Ashwell, Jonathan
|
CCR (NCI)
|
|
DNA repair alterations in metastatic prostate cancer: functional and therapeutic implications
|
1R01CA230516-01
|
$564,655
|
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
2P30CA082103-19
|
$7,954,381
|
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Targeting Nodal/TGF-Beta pathway to inhibit invasion and growth of retinoblastoma
|
1R21CA229919-01
|
$213,694
|
|
ASNAGHI, LAURA
|
JOHNS HOPKINS UNIVERSITY
|
|
Nutritionally Driven Sporadic Intestinal Tumors: Impact on Stem Cells
|
1R01CA229216-01
|
$493,238
|
|
AUGENLICHT, LEONARD
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Integrative framework for identifying dysregulated mechanisms in the tumor-immune microenvironment
|
1K99CA230195-01
|
$134,632
|
|
AZIZI, ELHAM
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Identifying predictors of racial disparity in treatment and mortality among patients diagnosed with breast cancer in South Carolina and geospatial investigation of breast cancer patient navigation
|
5F99CA222722-02
|
$39,707
|
|
BABATUNDE, OLUWOLE
|
UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA
|
|
Novel ODC Inhibitor Phaseolotoxin in Neuroblastoma
|
1R21CA216867-01A1
|
$193,750
|
|
BACHMANN, ANDRE
|
MICHIGAN STATE UNIVERSITY
|
|
The Duke Preclinical Research Resources for Quantitative Imaging Biomarkers
|
5U24CA220245-02
|
$631,958
|
|
BADEA, CRISTIAN
|
DUKE UNIVERSITY
|
|
Inter-relationship between microbiota diversity, obesity and race in endometrial cancer
|
5R21CA220269-02
|
$169,106
|
|
BAE-JUMP, VICTORIA
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
SPORE in Bladder Cancer
|
1P50CA221745-01A1
|
$2,299,837
|
|
BAJORIN, DEAN
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Implementation and Impact of Cancer Screening Navigation by Community Health Workers in Two National Screening Programs
|
1K01CA229996-01
|
$154,723
|
|
BARRINGTON, WENDY
|
UNIVERSITY OF WASHINGTON
|
|
Epigenomic and transcriptomic markers of aggressive prostate cancer among African American men
|
1K07CA230182-01
|
$138,094
|
|
BARRY, KATHRYN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
Molecular and Imaging Assessment of Fallopian Tube Health
|
1R21CA229707-01
|
$188,966
|
|
BARTON, JENNIFER
|
UNIVERSITY OF ARIZONA
|
|
U.T. M. D. Anderson Cancer Center SPORE in Ovarian Cancer
|
5P50CA217685-02
|
$1,813,624
|
|
BAST, ROBERT
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
DNA Repair Capacity Assays for Lung Disease Risk Assessment
|
1U01CA232505-01
|
$684,671
|
|
BELINSKY, STEVEN
|
LOVELACE BIOMEDICAL & ENVIRONMENTAL RES
|
|
Family-building After Cancer: Preferences, Decisions, and Planning for Young Female Survivors
|
1K07CA229186-01
|
$139,879
|
|
BENEDICT, CATHERINE
|
FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
|
|
Brain Tumor SPORE Grant
|
2P50CA097257-16
|
$2,498,496
|
|
BERGER, MITCHEL
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
PSMA - Targeted Small-Molecule Drug Conjugates
|
1R21CA223121-01A1
|
$199,665
|
|
BERKMAN, CLIFFORD
|
WASHINGTON STATE UNIVERSITY
|
|
Development of a surrogate liquid biopsy from the aqueous humor in retinoblastoma eyes.
|
1K08CA232344-01
|
$228,758
|
|
BERRY, JESSE
|
CHILDREN'S HOSPITAL OF LOS ANGELES
|
|
Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AID
|
ZIA SC 004020
|
$2,592,300
|
$259,230
|
Berzofsky, Jay
|
CCR (NCI)
|
|
Interrogating malignant gliomas using released tumor DNA in cerebrospinal fluid
|
1R37CA230400-01
|
$374,578
|
|
BETTEGOWDA, CHETAN
|
JOHNS HOPKINS UNIVERSITY
|
|
Validation and Advanced Development of Albumin Oxidizability as a Marker of Plasma/Serum Integrity
|
1R33CA217702-01A1
|
$364,966
|
|
BORGES, CHAD
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Yale SPORE in Skin Cancer
|
2P50CA121974-11A1
|
$2,500,000
|
|
BOSENBERG, MARCUS
|
YALE UNIVERSITY
|
|
Targeting the GPC2 oncoprotein with immune-based therapies in neuroblastoma
|
1K08CA230223-01
|
$202,195
|
|
BOSSE, KRISTOPHER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Targeting Musashi-2 (MSI2) regulation of EGFR and HER2 in lung cancer
|
1R21CA223394-01A1
|
$199,013
|
|
BOUMBER, YANIS
|
RESEARCH INST OF FOX CHASE CAN CTR
|
|
Identification of genomic drivers of brain metastases in renal cell carcinoma
|
1R21CA220253-01A1
|
$239,041
|
|
BRASTIANOS, PRISCILLA
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
DESI-MS detection of positive margins in kidney cancer
|
1R21CA229933-01
|
$170,738
|
|
BROOKS, JAMES
|
STANFORD UNIVERSITY
|
|
Pro-Codes: A novel vector and cell barcoding technology
|
1R33CA223947-01A1
|
$421,587
|
|
BROWN, BRIAN
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
The role of Fusobacterium in colorectal cancer treatment, tumor ecology and chemotherapeutic efficacy
|
1K99CA229984-01
|
$128,963
|
|
BULLMAN, SUSAN
|
DANA-FARBER CANCER INST
|
|
Image-guided ultrasound ablation for precision targeting of prostate cancer
|
1R01CA230323-01
|
$580,217
|
|
BURDETTE, EVERETTE
|
ACOUSTIC MEDSYSTEMS, INC.
|
|
Treating high grade intraepithelial lesions of the anus with photodynamic therapy
|
1R21CA223366-01A1
|
$210,105
|
|
BUSCH, THERESA
|
UNIVERSITY OF PENNSYLVANIA
|
|
Study the Mechanism of Retinoblastoma Protein Mediated Androgen Receptor Transcriptional Repression Activity on DNA Replication
|
5R01CA211350-02
|
$348,844
|
|
CAI, CHANGMENG
|
UNIVERSITY OF MASSACHUSETTS BOSTON
|
|
African Center for the Advancement of Research Excellence (AfriCARE)
|
5P20CA210677-02
|
$258,384
|
|
CAMPBELL, THOMAS
|
UNIVERSITY OF COLORADO DENVER
|
|
Targeting of TCF4 PARylation in the vascular niche to obliterate chemoresistant hepatocarcinoma cells
|
1R21CA230098-01
|
$221,198
|
|
CAO, ZHONGWEI
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
A CD47-blocking oncolytic vaccinia virus for cancer therapy
|
5F30CA203270-03
|
$44,524
|
|
CAO, FELICIA
|
BAYLOR COLLEGE OF MEDICINE
|
|
Cancer Biology Training Program
|
2T32CA009676-26
|
$317,918
|
|
CASTRO, MARIA
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Early development of small molecule dendritic cell immunopotentiators for the treatment of solid tumors
|
1R01CA229818-01
|
$737,882
|
|
CHANDA, SUMIT
|
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST
|
Total relevant funding to Interferon for this search: $4,542,084
|